Early Access — free while we kick the tires
EdgarHawk

Ferguson Jeffrey W.

General Counsel

Officer
2 filings analyzed · 1 company · Latest 2025-08-13

Companies

Company Buys Sells Direction
Carlyle Group Inc. CG 0 6 Net selling

Activity

August 2025
2025-08-13 Carlyle Group Inc. CG
high
Sell
300,000 shares
$19,088,342
Significance 6/10

General Counsel Ferguson sells 300,000 CG shares (28.5% of holdings) for $19.1M at $62.37–$64.82 amid 39.2% 90-day rally.

Ferguson Jeffrey W., General Counsel at Carlyle Group Inc., executed 4 separate sales totaling 300,000 shares for $19,088,342.32 over August 11–12, 2025, reducing his holdings from 1,053,255 shares to 753,255 shares—a 28.5% reduction. The sales occurred at prices ranging from $62.37 to $64.82, with a blended average of $63.63, and the stock now trades at $65.43, near its 52-week high. Notably, this sale occurs after a sharp 90-day advance (+39.2%), though the stock remains unchanged from its 52-week peak. Ferguson's prior two sales at Carlyle (February 2025) showed 90-day declines of -11.8% and -10.0%, and his cross-ticker track record includes a 100% well-timed rate on sells (2 of 2 prior trades declined in the 90 days following), suggesting a pattern of selling into strength; however, the current rally's magnitude and the stock's proximity to its annual high warrant scrutiny of whether this sale reflects positioning ahead of a potential pullback or simply rebalancing after a sustained run-up.

February 2025
2025-02-20 Carlyle Group Inc. CG
high
Sell
250,000 shares
$13,264,562
Significance 6/10

General Counsel sells 250,000 CG shares for $13.3M at $53.06 avg; holds 1.10M post-sale

Ferguson Jeffrey W., General Counsel at Carlyle Group, executed two separate sales totaling 250,000 shares for $13,264,562.08 at a blended average price of $53.06. This represents an 18.6% reduction in his prior holdings of 1,345,123 shares, leaving him with 1,095,123 shares post-transaction. The sale occurred against a backdrop of significant company headwinds: Carlyle reported annual revenue growth of -33.2% and was unprofitable over its most recent full fiscal year, with a notably elevated P/E of 157.61 reflecting depressed earnings. The stock has declined 7.8% over the past 30 days and 8.7% from its 52-week high of $56.96, trading at $52.01 currently—only $0.95 above the blended sale price. The substantial size and speed of this sale (two transactions within one trading day) by a senior executive warrant examination of whether this reflects shifts in positioning or company outlook.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access